Unrestrained cleavage of Roquin-1 by MALT1 induces spontaneous T cell activation and the development of autoimmunity
Henrik Schmidt(Aarhus University Hospital), Vigo Heissmeyer(Helmholtz Zentrum München)
Cited by 11
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma
|Journal of Clinical Oncology|2020|226
Predictors of responses to immune checkpoint blockade in advanced melanoma
|Nature Communications|2017|201
Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma
|Journal of Translational Medicine|2015|53
Binding of NUFIP2 to Roquin promotes recognition and regulation of ICOS mRNA
|Nature Communications|2018|39